Alise Reicin

Insider Reports History

Entity
Individual
Location
C/O Celgene Corporation, 86 Morris Avenue, Summit, NJ
Signature
/s/ Daniel Lochner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alise Reicin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tectonic Therapeutic, Inc. Chief Executive Officer, Director Common Stock 178K $424K $2.38 Dec 4, 2024 Direct
Homology Medicines, Inc. Director Option (Right to Buy) 23K $309K $13.42 Jun 14, 2023 Direct
Tectonic Therapeutic, Inc. Chief Executive Officer, Director Common Stock 125K $296K $2.38 Dec 4, 2024 By Trust
Tectonic Therapeutic, Inc. Chief Executive Officer, Director Employee Stock Option (Right to Buy) 290K Jun 20, 2024 Direct
Sana Biotechnology, Inc. Director Stock Option (Right to Buy) 65K Jun 6, 2024 Direct
Tectonic Therapeutic, Inc. Chief Executive Officer, Director Employee Stock Option (Right to Buy) 6K Dec 4, 2024 Direct

Insider Reports Filed by Alise Reicin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TECX Tectonic Therapeutic, Inc. Dec 4, 2024 2 $0 4 Dec 6, 2024 Chief Executive Officer, Director
TECX Tectonic Therapeutic, Inc. Jun 20, 2024 5 $0 4 Jun 24, 2024 Chief Executive Officer, Director
TECX Tectonic Therapeutic, Inc. Jun 20, 2024 0 $0 3 Jun 24, 2024 Chief Executive Officer, Director
SANA Sana Biotechnology, Inc. Jun 6, 2024 1 $0 4/A Jul 15, 2024 Director
SANA Sana Biotechnology, Inc. Jun 6, 2024 1 $0 4 Jun 7, 2024 Director
FIXX Homology Medicines, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
SANA Sana Biotechnology, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
FIXX Homology Medicines, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
SANA Sana Biotechnology, Inc. Jun 6, 2022 1 $0 4 Jun 8, 2022 Director
FIXX Homology Medicines, Inc. Jun 17, 2021 1 $0 4 Jun 22, 2021 Director